Full Text View
Tabular View
No Study Results Posted
Related Studies
Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine
This study has been completed.
Study NCT00297856   Information provided by GlaxoSmithKline

First Received on February 28, 2006.   Last Updated on May 2, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Diphtheria
Tetanus
Tetany
Whooping Cough
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Bordetella Infections
Calcium Metabolism Disorders
Clostridium Infections
Corynebacterium Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Hypocalcemia
Infection
Metabolic Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Manifestations
Respiratory Tract Diseases
Respiratory Tract Infections
Signs and Symptoms
Interventions listed in this trial
Boostrix®
Td (Tetanus diphtheria) vaccine
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services